Personalized medicine leverages decades of breakthroughs in science and healthcare to provide patients with precise treatment options for their specific case. Ashion® is dedicated to accelerating the use of personalized genomic information to provide patients with the right treatment for their disease.

  • Right Drug. Right Time.

    The Ashion Analytics™ team is led by internationally recognized doctors and scientists whose innovations in clinical genomics helped launch the field of Precision Medicine. With premier next-generation cancer analysis, we can provide a more complete biological picture of your cancer.

  • Cancer and DNA

    Damage to cancer-causing genes can now be easily and affordably detected through direct sequence analysis of the tumor. Scientists and doctors have used this knowledge to develop new approaches to personalized cancer treatment.

  • Genomic-Enabled Medicine (GEM) Cancer Panel™

    Therapeutic options for cancer treatment should not be "one-size-fits-all". The Genomic-Enabled Medicine (GEM) Cancer Panel™ is a medical test that detects damage in any of several hundred genes that may be a contributing cause of your cancer. These findings may help your doctor identify personalized treatment options best suited for you.

Easy-to-Understand Reports


The GEM (Genomic-Enabled Medicine) Cancer Panel™ Report summarizes the key findings from your genomic test in an easy-to-read format. The report focuses on the damaged gene(s) in support of the option(s) for your personalized treatment. This report is meant for your healthcare provider to review with you.

Outlines information about you, your doctor and your blood and tumor samples.

Includes the Tumor Genomic Alterations, which are the headline findings for the report. This section is a list of genes identified as being damaged in your cancer but not in your normal DNA. These are key genes that your doctor can use to aide in your personalized treatment decisions.

States your cancer diagnosis as provided by your doctor when ordering the test. This is not based on the GEM Cancer Panel™ test results.

The Findings Table contains more detail, such as FDA approved drugs, potential clinical trials, as well as additional information for you doctor.

Next-Generation Sequencing and Ashion® can assist your physician in developing a tailored treatment plan just for you.